Targeted Metagenomic Sequencing for Pneumonia: Clinical Impact in Hematologic Malignancies

This expert presentation evaluates the clinical impact of targeted metagenomic sequencing compared with standard diagnostic approaches for pneumonia in patients with hematologic malignancies. Dr. Teny John presents experience from an immunocompromised patient population where rapid and accurate pathogen detection is critical.

The session focuses on how metagenomic NGS workflows can complement conventional diagnostics by improving pathogen identification and supporting decision‑making in complex infectious disease cases.

What you’ll learn:

• How targeted metagenomic sequencing compares with standard diagnostics in pneumonia

• The potential clinical value of NGS in immunocompromised patient populations

• Considerations for integrating metagenomic workflows into microbiology laboratories

Presenter
Teny John, MD
Associate Professor, Department of Infectious Diseases
The University of Texas MD Anderson Cancer Center, USA